Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 4/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | EBP | Q15125 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3037072 | 1.00 | MEN1 (0.61) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| Sulfuric Acid SCHEMBL9223828 | 0.89 | MEN1 (0.51) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL11629435 | 0.89 | KCNH2 (0.50) | MEN1KMT2AKCNH2KDM4ECYP1A2 | |
| SCHEMBL11629438 | 0.89 | KCNH2 (0.50) | MEN1KMT2AKCNH2KDM4ECYP1A2 | |
| SCHEMBL9779068 | 0.87 | MEN1 (0.53) | MEN1KMT2AKCNH2KDM4EHTR2A | |
| SCHEMBL2774559 | 0.87 | MEN1 (0.63) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL2774560 | 0.87 | MEN1 (0.63) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| Hydrochloric Acid SCHEMBL8070534 | 0.86 | MEN1 (0.51) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL11387658 | 0.84 | KCNH2 (0.47) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL11496361 | 0.84 | EPOR (0.52) | MEN1KMT2AKCNH2L3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10155735-B2 | Synthesis of novel ionic liquids from lignin-derived compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-12-18 | — | — | US | disclosed |
| US-20170349561-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2017-12-07 | — | — | US | disclosed |
| US-20170349561-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2017-12-07 | — | — | US | disclosed |
| US-20170349561-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2017-12-07 | — | — | US | disclosed |
| US-9765044-B2 | Synthesis of novel ionic liquids from lignin-derived compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-09-19 | — | — | US | disclosed |
| US-9765044-B2 | Synthesis of novel ionic liquids from lignin-derived compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-09-19 | — | — | US | disclosed |
| US-9765044-B2 | Synthesis of novel ionic liquids from lignin-derived compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-09-19 | — | — | US | disclosed |
| US-20160031843-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2016-02-04 | — | — | US | disclosed |
| US-20160031843-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2016-02-04 | — | — | US | disclosed |
| US-20160031843-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2016-02-04 | — | — | US | disclosed |
| US-7674823-B2 | DNA-PK inhibitors | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2010-03-09 | — | — | US | disclosed |
| EP-2102286-A1 | BLOCKED ISOCYANATE SILICONE RESINS | Dow Corning Corporation (US) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008088492-A1 | BLOCKED ISOCYANATE SILICONE RESINS | DOW CORNING CORPORATRION (US) | 2008-07-24 | — | — | WO | disclosed |
| US-20070238729-A1 | DNA-PK INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| US-20070238729-A1 | DNA-PK INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| US-20070167587-A1 | Process for producing polymer with functional end | KURARAY CO., LTD. (JP) | 2007-07-19 | — | — | US | disclosed |
| US-7226918-B2 | DNA-PK inhibitors | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-06-05 | — | — | US | disclosed |
| EP-1420008-B1 | Composition, in particular cosmetic, comprising a secondary or tertiary amine | OREAL (FR) | 2006-12-20 | — | — | EP | disclosed |
| EP-1721912-A1 | PROCESS FOR PRODUCING POLYMER WITH FUNCTIONAL END | KURARAY CO., LTD. (JP) | 2006-11-15 | — | — | EP | disclosed |
| EP-1420008-A1 | Composition, in particular cosmetic, comprising a secondary or tertiary amine | L'OREAL (FR) | 2004-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160031843-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | DCXR, LCT, LARS1 | MEN1 4560/4885KMT2A 593/4885KCNH2 1732/4885 |
| US-20070238729-A1 | DNA-PK INHIBITORS | ATM, CHEK2, CHEK1 | MEN1 3398/4885KMT2A 1306/4885KCNH2 1887/4885 |
| US-10155735-B2 | Synthesis of novel ionic liquids from lignin-derived compounds | LSS, DCXR, MYB | MEN1 4291/4885KMT2A 1412/4885KCNH2 2639/4885 |
| US-20170349561-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | LSS, DCXR, MYB | MEN1 4291/4885KMT2A 1412/4885KCNH2 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.